Treatment of infectious keratoconjunctivitis in animals

Details Treatment of infectious keratoconjunctivitis in animals Treatment of infectious keratoconjunctivitis in animals

1979-03-23

1980-08-26

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Conjugate or complex of monoclonal or polyclonal antibody,...

Conjugated via claimed linking group, bond, chelating agent,...

424227, 424252, A61K 3165, A61K 3171, A61K 31525

Patent

active

042195454

ABSTRACT:
The oral administration to animals of riboflavin is an effective therapeutic treatment for keratoconjunctivitis. Suitable riboflavin dosages for this treatment are in the nature of from about 65 milligrams to about 200 milligrams per animal per day. The riboflavin may be orally administered by mixing with ground feed or corn or by incorporation with mineral salt into a salt lick. Additional ingredients with the riboflavin such as antibiotics, vitamin A and other vitamins assist in the treatment. Suitable antibiotics include tetracycline, neomycin, and oxytetracycline.

REFERENCES:
patent: 2388261 (1945-11-01), Front
patent: 3754084 (1973-08-01), Fujie et al.
Chem. Abst. 67 47089(j) (1967)-Saikovs'ka et al.
Chem. Abst. 80 55814(a) (1974)-Lipkan et al.
Chem. Abst. 81 86059(h) (1974)-Lipkan et al.

Affiliated with

Also associated with

Rating

Treatment of infectious keratoconjunctivitis in animals does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of infectious keratoconjunctivitis in animals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of infectious keratoconjunctivitis in animals will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1305517